ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,583.20
      -2.09%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.24%
      Bitcoin
      64,169.35
      1.04%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Tarsus Pharmaceuticals Inc (TARS)

      7. Tarsus Pharmaceuticals Inc (TARS) News

      TARS Tarsus Pharmaceuticals Inc

      32.44
      -0.41 (-1.25%)
      After Hours
      Last Updated: 16:43:18
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Tarsus Pharmaceuticals Inc TARS NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.41 -1.25% 32.44 16:43:18
      Open Price Low Price High Price Close Price Prev Close
      32.44 31.72 33.69 32.44 32.85
      more quote information »

      Recent News

      Date Time Source Heading
      3/11/202417:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202417:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/11/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202416:30GLOBETarsus to Participate at Upcoming Investor Conferences
      3/05/202416:09EDGAR2Form 8-K - Current report
      3/05/202408:30GLOBETarsus Introduces “Mite Party” Campaign for XDEMVY®..
      3/01/202417:26EDGAR2Form 8-K - Current report
      3/01/202417:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/01/202400:07GLOBETarsus Announces Pricing of $100.0 Million Public Offering
      2/29/202417:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/29/202416:37GLOBETarsus Announces Proposed $100.0 Million Public Offering
      2/29/202416:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
      2/27/202416:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/27/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/27/202406:00GLOBETarsus Reports Strong Fourth Quarter and Full-Year 2023..
      2/22/202408:00GLOBETarsus Announces Positive Topline Results from Carpo, a..
      2/20/202417:00GLOBETarsus to Report Fourth Quarter and Full Year 2023 Financial..
      1/31/202417:00GLOBETarsus to Participate in Fireside Chat at the Sixth Annual..
      1/30/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/18/202416:30EDGAR2Form 8-K - Current report
      1/08/202409:00EDGAR2Form 8-K - Current report
      12/29/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/27/202316:23EDGAR2Form 144 - Report of proposed sale of securities
      12/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202316:49EDGAR2Form 144 - Report of proposed sale of securities
      12/19/202318:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202309:01EDGAR2Form 8-K - Current report
      12/11/202308:00GLOBETarsus Announces Positive Topline Results from the Ersa..
      12/01/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/30/202316:35EDGAR2Form 144 - Report of proposed sale of securities
      11/30/202316:15EDGAR2Form 144 - Report of proposed sale of securities
      11/22/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      11/17/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202316:53EDGAR2Form 144 - Report of proposed sale of securities
      11/09/202316:18EDGAR2Form S-3 - Registration statement under Securities Act of..
      11/09/202316:05EDGAR2Form 8-K - Current report
      11/09/202316:05GLOBETarsus Reports Third Quarter 2023 Financial Results and..
      11/09/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/01/202318:35GLOBETarsus to Report Third Quarter 2023 Financial Results on..
      10/20/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/18/202316:26EDGAR2Form 144 - Report of proposed sale of securities
      9/22/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/20/202316:30EDGAR2Form 144 - Report of proposed sale of securities
      9/06/202308:00GLOBETarsus to Ring Nasdaq Stock Market Closing Bell in..
      8/30/202316:30GLOBETarsus to Present at Upcoming Investor Conferences
      8/25/202317:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/24/202309:00GLOBENow Available – XDEMVY™ (lotilaner ophthalmic solution)..

      Your Recent History

      NASDAQ
      TARS
      Tarsus Pharmaceuticals
      Delayed Upgrade Clock